Publications

Division/Center

Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.

PLoS ONE
Hsu JC, Wu HC, Feng WC, Chou CH, Lai EC, Lu CY

Provider Perspectives on Quality Payment Programs Targeting Diabetes in Primary Care Settings.

Popul Health Manag
Garabedian LF, Ross-Degnan D, Wharam JF

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees

JAMA Netw Open
Wen H, Hockenberry JM, Pollack HA

Access to essential medicines in 195 countries: A human rights approach to sustainable development

Glob Public Health
Perehudoff SK, Alexandrov NV, Hogerzeil HV

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans

Breast Cancer Res Treat
Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L Ross-Degnan D, Wharam JF

Availability and affordability of medicines: towards an evidence base for routine assessment.

Lancet Diabetes Endocrinol
Ferrario A

Peripartum Maternal Hepatitis B Care in a US Nationwide Data Set.

J. Clin. Gastroenterol.
Chang MS, Wharam JF, Zhang F, LeCates RF, Morton-Eggleston E, Tuomala RE, Rutherford AE, Mutinga ML, Andersson KL, Brown RS, Ukomadu C, Oken E

Trends in advanced imaging and hospitalization for emergency department syncope care before and after ACEP clinical policy.

Am J Emerg Med
Chou SC, Nagurney JM, Weiner SG, Hong AS, Wharam JF

Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs.

Drug Saf
Gagne JJ, Popovic JR, Nguyen M, Sandhu SK, Greene P, Izem R, Jiang W, Wang Z, Zhao Y, Petrone AB, Wagner AK, Dutcher SK

The effect of mammography screening regimen on incidence-based breast cancer mortality.

J Med Screen
Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.

Health Policy
Morgan SG, Good CB, Leopold C, Kaltenboeck A, Bach PB, Wagner A

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China.

BMJ Open
Guan X, Tian Y, Ross-Degnan D, Man C, Shi L

Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities.

J Pharm Policy Pract
Trap B, Musoke R, Kirunda A, Oteba MO, Embrey M, Ross-Degnan D

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices.

Qual Manag Health Care
Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK

Estrogen-receptor status and risk of contralateral breast cancer following DCIS.

Breast Cancer Res. Treat.
Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS

Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease.

Pharmacoepidemiol Drug Saf
Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA

Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.

Br J Clin Pharmacol
Lu CY, Soumerai SB

How the Uruguayan Judiciary Shapes Access to High-Priced Medicines: A Critique through the Right to Health Lens

Health and Human Rights Journal
Pizzarossa Berro L, Perehudoff K, Forte Castela J

A Methodological Framework for Model Selection in Interrupted Time Series Studies

J Clin Epidemiol
Lopez Bernal J, Soumerai S, Gasparrini A.

Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages.

Health Aff (Millwood)
Haffajee RL, Mello MM, Zhang F, Zaslavsky AM, Larochelle MR, Wharam JF